2 results · Page 1 of 1

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Assessment of Effectiveness and Safety of Luspatercept in Patients Suffering From Lower-risk Myelodysplastic Syndrome.Hemic and Lymphatic Diseases, bone marrow disorder, hematologic disorder, myelodysplastic syndromeActive, not recruitingPhase 32025-09-30NCT05181592
COMPERA / COMPERA-KIDSCardiovascular Abnormalities, Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Eisenmenger syndrome, cardiovascular disorder, congenital heart disease, heart disorder, hypertensive disorder, lung disorder, pulmonary arterial hypertension, pulmonary hypertension, respiratory system disorder, vascular disorderRecruitingNot stated2025-08-24NCT01347216